You are here: Industry Insights > COVID-19

News List

Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays prnewswire
July 02, 2020
Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and ...
Health Canada approves phase 2a Covid-19 trial of NuvOx’s oxygen therapeutic pharmaceutical-business-review
July 02, 2020
NuvOx Pharma, a Tucson-based biotechnology company developing NanO2 emulsion for oxygen delivery, has received a “No Objection Letter” from Health Canada to proceed with a Phase IIa clinical trial of NanO2 in COVID-19 subjects with acute ...
ViiV selects projects for HIV/COVID-19 response fund pharmatimes
July 02, 2020
ViiV Healthcare has announced that 109 projects from 26 countries are to get financial support from its Global HIV and COVID-19 Emergency Response Fund.
Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction worldpharmanews
July 02, 2020
SARS-CoV-2, the coronavirus causing the global COVID-19 pandemic, uses a protein called polymerase to replicate its genome inside infected human cells.
Palatin to Develop Potential Treatment for COVID-19, Associated Lung Complications americanpharmaceuticalreview
July 02, 2020
Palatin Technologies is developing PL8177 as a treatment for patients with COVID-19, the disease caused by infection with the SARS-CoV-2 virus, and having hypoxemic respiratory failure with or without acute respiratory distress syndrome (ARDS).
Therapeutic Solutions to Use Clinical Stage NK Activating Cancer Immunotherapy for COVID-19 americanpharmaceuticalreview
July 02, 2020
Therapeutics Solutions has announced plans to utilize its clinical-stage cancer immunotherapy StemVacs? for treatment of COVID-19 patients.
Meissa begins pre-clinical studies of Covid-19 intranasal vaccine pharmaceutical-technology
July 02, 2020
US-based biotechnology company Meissa Vaccines has started preclinical studies and manufacturing of its intranasal, live attenuated vaccine (LAV) candidate MV-014-210 against Covid-19.
Big bio/pharma companies sales bolstered by COVID-19: GlobalData expresspharma
July 02, 2020
This increase was due to stockpiling by people in preparation for reduced medical access in the lockdown.
Hoth Therapeutics Announces Sponsored Research Agreement with VCU for Potential COVID-19 Treatment prnewswire
July 01, 2020
Hoth Therapeutics, Inc., a biopharmaceutical company, announced entering into a sponsored research agreement with Virginia Commonwealth University (VCU) for a potential COVID-19 treatment.
Even in the worst COVID-19 cases, the body launches immune cells to fight back worldpharmanews
July 01, 2020
A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19 patients produce T cells that help fight the virus.